Medindia
Medindia LOGIN REGISTER
Advertisement

Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2019 and Highlights Recent Corporate Progress

Thursday, May 9, 2019 General News
Advertisement

HERON THERAPEUTICS, INC.Condensed Consolidated Balance Sheet Data(in thousands)

March 31,

December 31,

2019

2018

(unaudited)

Cash, cash equivalents and short-term investments

$       289,238

$        332,371

Accounts receivable, net

74,007

64,652

Total assets

435,794

462,179

Total stockholders' equity

331,814

370,160

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close